Others prescribe the stack from day one for patients specifically focused on body composition
Well, you've come to the right place
The FDAs decision to ban BPC-157 and other peptides stems from concerns over safety, citing insufficient data, impurities, and potential adverse immune reactions
Unlike enrolling in a formal clinical trial (which has extensive consent forms explaining experimental status), patients at wellness clinics might assume if a doctor offered it, it must be safe or allowed. Such misunderstandings could lead to feelings of betrayal and litigation if things go wrong
further notes that, in response to a Freedom of Information request asking for the clinical evidence for the three monthly maintenance dose, the Medicines and Healthcare products Regulatory Agency stated that they were unable to obtain this information
If youre concerned about stopping and symptom return, see Transitioning Off BPC-157 TB-500